Zach Taylor is a business development professional with over 20 years experience in biotech, pharma and medtech industries.  He currently serves as Vice President Corporate Development & Strategy for BioNTech USA.  Zach incubated the company as Neon Therapeutics as a consultant to Third Rock Ventures, leading diligence and helping create the company business plan culminating in a $55 million Series A financing in 2015.  Zach was also a key contributor to Neon’s IPO process in 2018. Prior to Neon, Zach held a number of business development roles and strategy roles at companies including Syros Pharmaceuticals, Millennium Pharmaceuticals (acquired by Takeda) and Philips Research in the Netherlands.   While at Philips, Zach co-founded Tagworks Pharmaceuticals and helped spin the company out of Philips.  Zach holds a BS in Engineering Physics from Cornell University and earned his MBA from the Kellogg School of Business – Northwestern University.